A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Group Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The fact that Cognitive Behavioral Therapy (CBT) is a well known efficacious intervention for children with anxiety disorders (AD) is undeniable. However, most children with AD have limited access to CBT. There is some controversial evidence on group CBT in AD involving families in treatment of their children and a published article on efficacy of a parent only group CBT for these children. Considering these data, the investigators hypothesized that teaching anxiety-fighting skills to parents of children with AD would diminish anxiety symptoms of both parents and children and improve family relational functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 16, 2012
CompletedFirst Posted
Study publicly available on registry
January 20, 2012
CompletedApril 26, 2016
April 1, 2016
10 months
January 16, 2012
April 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Revised Children's Manifest Anxiety (RCMA)
This self report questionnaire consists of 28 items assessing a child's chronic or trait anxiety and 9 items assessing social desirability or potential lying. The RCMA has achieved a high internal consistency and moderate test-retest reliability.
up to 30 minutes
Secondary Outcomes (6)
Children's Depression Inventory (CDI)
20 minutes
Depression-Anxiety-Stress Scale (DASS)
20 minutes
Children Global Assessment Scale (CGAS)
15 minutes
Assessment of Consumer Satisfaction
25 minutes
Strengths and Difficulties Questionnaire (SDQ) Home Version
[Time Frame: 30 minutes]
- +1 more secondary outcomes
Study Arms (2)
A parent only group CBT
ACTIVE COMPARATORThere was a Group cognitive behavioral intervention -based on parent training component of "FRIENDS" program- for parents of children with anxiety disorders who were allocated to intervention group.
Waiting list group
NO INTERVENTIONParents of children with anxiety disorders who met the inclusion criteria and gave written informed consent and were allocated to wait list group.
Interventions
A Group cognitive behavioral intervention \_based on parent training component of FRIENDS program\_ was performed.The program protocol was translated to Persian, using the back translation method.The intervention was delivered in 6 two-hour weekly sessions. Two intervention groups ran, each group included 10 parents.The therapy was provided by an attending board certified child and adolescent psychiatrist and co lead by a fellow of child and adolescent psychiatry who distributed psychometric procedures and completed treatment adherence ratings.
Eligibility Criteria
You may qualify if:
- having DSM-IV criteria for a primary diagnosis of generalized anxiety disorder (GAD), separation anxiety disorder (SAD), social phobia, or specific phobia.
- age 6 to 12 years,
- receiving one of selective serotonin reuptake inhibitor (SSRI) medicine at the stable dose for at least 8 weeks before baseline assessments and during the study,
- at least one parent willing to participate and give written consent.
You may not qualify if:
- diagnosed as bipolar disorder, autism spectrum disorders or mental disability by data obtained in personal history and clinical assessments,
- there was a change in drug regime during the study period,
- if parents missed more than 2 of 6 sessions of treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rouzbeh Hospital
Tehran, Tehran Province, 13333, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zahra Shahrivar, MD
Tehran University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 16, 2012
First Posted
January 20, 2012
Study Start
July 1, 2008
Primary Completion
May 1, 2009
Study Completion
July 1, 2009
Last Updated
April 26, 2016
Record last verified: 2016-04